Skip to main content

Infusion Pump Market Segmental Revenue, Technology, Future Trends, Industry Size, Challenges

 Infusion Pump Market Share, Trends And Growth Analysis By Type (Volumetric Pump, Syringe Pump, & Others), By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics & Others), By End User (Hospitals, Ambulatory Surgical Centers, Homecare & Others) - Forecast To 2023

Global Infusion pump Market - Overview

Infusion pumps are the medical devices which are used to deliver medication or nutrient to the body. They deliver the controlled amount of fluids and thus are helpful in delivering medication in diseases like diabetes. The major reason for the growth of this market is increasing prevalence of diseases like diabetes and cancer. Beside this increasing geriatric population and technological advances has provided fuel for the growth of the market.  For instance in May 2015, Pfizer has acquired Hospira Inc. and is the largest pharmaceutical overtake. This acquisition has increased the Pfizer’s market dramatically. Sapphire pumps which was launched by Hospira Inc. is boosting business.

Intended Audience

  • Infusion pump manufacturers and suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Academic Institutes and Universities

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/1509

The Global market for infusion pump is growing at a steady pace. The various factors that influence the growth of the market are increased use of infusion pumps for the delivery of drugs and other fluids, rising prevalence of chronic and fatal diseases, high demand of the infusion systems in the military medical units, technological advancements from the leading market players. Furthermore the factors such as patient safety concerns and improper infusion leading to the severe consequences, unmet medical needs in the low income countries are hamper the growth of the market. 

Global Infusion Pumps market is expected to grow at a CAGR of 5.2 % during forecasted period 2017-2023.

Global Infusion pump Market – Regional:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

North America has the largest market for global infusion pumps market. It contributes around 41% of total market of the world. US and Canada is the major contributor for the infusion pump market in North America. Due to a huge diabetic population and increasing aging population in this region is the major factor for the growth of this market in US and Canada. According to Centre of Disease Control and Prevention, in 2014 29 million people are suffering from diabetes in America which is about 9% of total Americas population is suffering from diabetes. Beside this a huge aging population in America especially in Canada is the major driving factor for the growth of infusion pumps market in North America. Beside this improvement in healthcare sector and increase in the demand for the infusion pumps are the other factor providing fuel for the growth of the market.

Europe is the second largest market for the infusion pumps. Europe infusion pumps market is driven by growing disease burden in oncology and diabetes, increase in demand of infusion pumps form home care patient and increasing in geriatric population. About 10% of the total Europe population suffers from diabetes and amongst total cancer death in the world 20% occur in Europe. Due to increase in the prevalence of diseases like diabetes and cancer in Europe is the major factor for increasing the market. Germany, France and UK are the major contributor to this market in Europe. About 70% of total Europe infusion pump market is acquired by this three countries.

Asia-Pacific is the fastest growing region for infusion pump market. Due to rapid development in healthcare sector and continuously increasing diabetic population is the important driving factor for the market. Huge population base in this region has attracted many of the major companies to develop there market in this region.

Access Report Details @  https://www.marketresearchfuture.com/reports/infusion-pumps-market-1509

CareFusion Corporation (US), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Smiths Medical (U.K.), Becton Dickinson & Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Pfizer, Inc. (U.S.),  Fresenius Kabi  (Germany), Roche Diagnostics (Switzerland), Moog Inc (U.S.), Asante (US), Biomedical Solutions (US),  Flowonix Medical Inc (US), Hospira, Inc (US), Micromed (UK), Mircel Medical Device (Greece), Q-Core (Israel), Stryker (US), 3M (U.S.), ICU Medical, Inc. (U.S.), and Terumo Medical Corporation (Japan) are some of the prominent players at the forefront of competition in the global  infusion pump market and are profiled in MRFR Analysis.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more